Journals / Türk Nöroşirürji Dergsi / 2017 / Cilt: 27 - Sayı: 3

Epidemiology of Craniosynostosis

Kraniosinostoz Epidemiyolojisi

Pages
227–230
Publication Date
2022-11-04
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

For individuals where there is no definable aetiology, or those in whom a specific syndrome or chromosomal diagnosis cannot be identified, the recurrence risk for relatives and offsprings will be empiric and largely depend on the outcome of a careful clinical examination

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Craniosynostosis can be defined as early fusion or absence of cranial sutures.
📊
Key Findings & Data:The general prevelance is about 1/2500.
💡
Conclusion & Impact:For individuals where there is no definable aetiology, or those in whom a specific syndrome or chromosomal diagnosis cannot be identified, the recurrence risk for relatives and offsprings will be empiric and largely depend on the outcome of a careful clinical examination
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Craniosynostosis can be defined as early fusion or absence of cranial sutures. The general prevelance is about 1/2500. It can be divided into two main groups as syndromic and nonsyndromic craniosynostosis. Syndromic ones make up nearly 15-20% of the whole group. The most common forms are the Apert and Crouzon Syndromes. Nonsyndromic craniosynostosis involves 80-85% of the whole pathology. The most frequent form is sagittal synostosis. The coronal synostosis group makes up 20-30% of the surgical cases. Besides genetic factors, some teratogens such as anticonvulsants, cytotoxic agents, and nitrosatable drugs are thought to be effective in the etiopathogenesis. For individuals where there is no definable aetiology, or those in whom a specific syndrome or chromosomal diagnosis cannot be identified, the recurrence risk for relatives and offsprings will be empiric and largely depend on the outcome of a careful clinical examination

Özet

Kraniosinostoz, kranial sütürlerin erken füzyonu ya da yokluğu olarak özetlenebilir. Genel prevelans 1/2500 civarındadır. Sendromik ve nonsendromik olmak üzere iki ana gruba ayrılır. Sendromik kraniosinostozlar, tüm kraniosinostozların %15-20 civarını oluştururlar. En sık görülenler Apert ve Crouzon Sendromlarıdır. Nonsendromik kraniosinostozlar %80-85'lik büyük grubu oluştururlar. En sık sagital sinostoz görülür. Tüm cerrahi olguların %20-30'unu koronal sinostoz grubu oluşturur. Genetik nedenlerin yanı sıra antikonvülzanlar, sitotoksik ajanlar ve nitrozlayıcılar gibi bazı teratojenlerin de oluşumda etkili olduğu bilinmektedir. Tanımlanabilen kesin bir etiyolojik ajan saptanamayan, özgün bir sendrom ya da kromozomal tanı belirlenemeyen olgularda akrabalar ve etkilenen bireyin gelecekteki çocukları açısından rekürrens riski ampirik olarak ifade edilebilir ve genellikle özenli bir klinik değerlendirmenin sonuçlarına bağlıdır

🔖

Cite This Article

ÖNAL, Ç., PAŞAHAN, R. (2022). Epidemiology of Craniosynostosis. Türk Nöroşirürji Dergsi, Cilt: 27 - Sayı: 3, 227–230. https://ajindex.com/articles/637429

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (1)

  1. Arnaud E, Meneses P, Lajeunie E, Thorne JA, Marchac D, Renier D: Postoperative mental and morphological outcome for nonsyndromic brachycephaly. Plast Reconstr Surg 110 (1):6-12; discussion 13, 2002 2. Boulet SL, Rasmussen SA, Honein MA: A population-based study of craniosynostosis in metropolitan Atlanta, 1989-2003. Am J Med Genet A 146A(8):984-991, 2008 3. Butzelaar L, Breugem CC, Hanlo P, Mink van der Molen AB: Is isolated sagittal synostosis an isolated condition? J Craniofac Surg 20(2):399-401, 2009 4. Carmichael SL, Ma C, Rasmussen SA, Honein MA, Lammer EJ, Shaw GM: Craniosynostosis and maternal smoking. Birth Defects Res A Clin Mol Teratol 82(2):78–85, 2008 5. Cohen MM Jr, Kreiborg S: Visceral anomalies in the Apert syndrome. Am J Med Genet 45(6):758-760, 1993 6. Cohen MM Jr, Kreiborg S: Birth prevalence studies of the Crouzon Syndrome: Comparison of direct and indirect methods. Clinical Genet 41(1):12-15, 1992 7. Çeltikçi E, Börcek AÖ, Baykaner MK: Kraniyosinostozlar. Türk Nöroşir Derg 23(2):132-137, 2013 8. David L, Glazier S, Pyle J, Thompson J, Argenta L: Classification system for sagittal craniosynostosis. J Craniofac Surg 20(2):279-282, 2009 9. Di Rocco F, Arnaud E, Renier D: Evolution in the frequency of nonsyndromic craniosynostosis. J Neurosurg Pediatr 4(1):21- 25, 2009 10. Dollfus H, Biswas P, Kumaramanickavel G, Stoetzel C, Quillet R, Biswas J, Lajeunie E, Renier D, Perrin-Schmitt F: Saethre-Chotzen Syndrome: Notable intrafamilial phenotypic variability. Am J Med Genet 109(3):218-225, 2002 11. Kapp-Simon KA, Speltz ML, Cunningham ML, Patel PK, Tomita T: Neurodevelopment of children with single suture craniosynostosis: A review. Childs Nerv Syst 23(3):269–281, 2007 12. Kimonis V, Gold JA, Hoffman TL, Panchal J, Boyadjiev SA: Genetics of craniosynostosis. Semin Pediatr Neurol 14(3):150– 161, 2007 13. Lajeunie E, Crimmins DW, Arnaud E, Renier D: Genetic considerations in nonsyndromic midline craniosynostoses: A study of twins and their families. J Neurosurg 103 Suppl 4:353-356, 2005 14. Lajeunie E, Barcik U, Thorne JA, El Ghouzzi V, Borgeois M, Renier D: Craniosynostosis and fetal exposure to sodium valproate. J Neurosurg 95(5):778-782, 2001 15. Marini R, Temple K, Chitty L, Genet S, Baraitser M: Pitfalls in counselling: The craniosynostoses. J Med Genet 28(2):117- 121, 1991 16. Mefford HC, Shafer N, Antonacci F, Tsai JM, Park SS, Hing AV, Rieder MJ, Smyth MD, Speltz ML, Eichler EE, Cunningham ML: Copy number variation analysis in single-s